PROCEPT BioRobotics Corp — Director's Dealing 2022

Dec 7, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROCEPT BioRobotics Corp (PRCT)
CIK: 0001588978
Period of Report: 2022-12-05

Reporting Person: Desai Antal Rohit (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-05	Common Stock	J	1726534	—	Disposed	5029869	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	40528	Indirect
Common Stock	258470	Indirect
Common Stock	107586	Indirect
Common Stock	54883	Direct

Footnotes

F1: Antal Desai, a member of the Issuer's board of directors, and Kent McGaughy, Jr., each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by each of White Tailed Ptarmigan, LP, Kestrel Fund, L.P. and Mallard Fund, L.P. (collectively, the "CPMG Funds") Mr. Desai disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein. Kent McGaughy, Jr., CPMG, Inc. and White Tailed Ptarmigan, LP jointly report their beneficial ownership of these shares on a separate Form 4.

F2: On December 5, 2022, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 236,734 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13.

F3: Includes shares previously held indirectly through White Tailed Ptarmigan, LP, which were distributed on a pro rata basis, for no consideration, on December 5, 2022, in a transaction exempt from Section 16 under Rules 16a-9 and 16a-13.

F4: Mr. Desai and his spouse serve as co-trustees of The 2:22 DNA Trust. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by The 2:22 DNA Trust except to the extent of any pecuniary interest therein.